tiprankstipranks
Santhera Pharmaceuticals Holding Ag (CH:SANN)
:SANN
Switzerland Market

Santhera Pharmaceuticals Holding (SANN) Income Statement

Compare
Followers

Santhera Pharmaceuticals Holding Income Statement

Last quarter (Q2 2024), Santhera Pharmaceuticals Holding's total revenue was CHF14.11M, an increase of 125.82% from the same quarter last year. In Q2, Santhera Pharmaceuticals Holding's net income was CHF-15.26M. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
CHF 103.41MCHF 7.47MCHF -1.59MCHF 15.01MCHF 75.38M
Gross Profit
CHF 100.18MCHF 3.88MCHF -5.36MCHF 4.58MCHF 69.93M
Operating Expenses
CHF 31.34MCHF 55.86MCHF 51.53MCHF 57.65MCHF 80.37M
Depreciation and Amortization
CHF 3.04MCHF 3.65MCHF 3.72MCHF 7.14MCHF 4.77M
EBITDA
CHF 79.17MCHF -46.78MCHF -34.57MCHF -53.43MCHF -7.54M
Operating Income
CHF 68.84MCHF -51.98MCHF -56.89MCHF -53.08MCHF -10.44M
Other Income/Expenses
CHF -14.02MCHF -18.64MCHF 2.17MCHF -14.38MCHF -7.95M
Pretax Income
CHF 54.82MCHF -70.62MCHF -54.72MCHF -67.46MCHF -18.39M
Net Income
CHF 54.78MCHF -71.08MCHF -55.53MCHF -67.66MCHF -18.97M
Per Share Metrics
CHF ―CHF ―CHF ―CHF ―CHF ―
Basic EPS
CHF 5.18CHF -11.67CHF -16.25CHF -50.81CHF -17.26
Diluted EPS
CHF 5.01CHF -11.67CHF -16.25CHF -50.81CHF -17.26
Weighted Average Shares Outstanding
10.58M 6.09M 3.42M 1.33M 1.10M
Weighted Average Shares Outstanding (Diluted)
10.92M 6.09M 3.42M 1.33M 1.10M
Currency in CHF

Santhera Pharmaceuticals Holding Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis